ArticleMetabolic brain disease2026
Exploring the therapeutic potential of the gut microbiota metabolite 3‑indolepropionic acid in parkinson's disease: a network pharmacology, molecular docking and cell viability study.
Qiuyue Zheng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.